[1] |
Wen Z, Pan T, Yang S, et al. Up-regulated NRIP2 in colorectal cancer initiating cells modulates the Wnt pathway by targeting RORβ [J]. Molecular Cancer, 2017, 16(1): 5260-5267.
|
[2] |
Chen W, Zheng R, Baade PD , et al. Cancer statistics in China, 2015 [J]. CA: A Cancer Journal for Clinicians, 2016, 66(2): 115-132.
|
[3] |
Yanyan C, Xianping R, Kangmao H, et al. FH535 Inhibits Proliferation and Motility of Colon Cancer Cells by Targeting Wnt/β-catenin Signaling Pathway [J]. Journal of Cancer, 2017, 8(16): 3142-3153.
|
[4] |
Yang K, Zhang F, Han P, et al. Metabolomics approach for predicting response to neoadjuvant chemotherapy for colorectal cancer [J]. Metabolomics, 2018, 14(9): 110-116.
|
[5] |
Zhou C, Cui F, Li J, et al. MiR-650 represses high-risk non-metastatic colorectal cancer progression via inhibition of AKT2/GSK3β/E-cadherin pathway [J]. Oncotarget, 2017, 8(30): 49534-49547.
|
[6] |
Li K, He Z, Wang X, et al. Apigenin C-glycosides of Microcos paniculata protects lipopolysaccharide induced apoptosis and inflammation in acute lung injury through TLR4 signaling pathway [J]. Free Radical Biology & Medicine, 2018, 124(9): 163-172.
|
[7] |
Yan T, Hu G, Wang A, et al. Paris saponin VII induces cell cycle arrest and apoptosis by regulating Akt/MAPK pathway and inhibition of P-glycoprotein in K562/ADR cells [J]. Phytotherapy Research, 2018, 32(5): 898-893.
|
[8] |
Babaer DA, Wang X. Activities of in vitro prepared recombinant wnt inhibitory factor-1 [J]. Cancer Research, 2016, 76(14): 4604.
|
[9] |
Li T, Zhang L, Huo X. Inhibitory effects of aesculetin on the proliferation of colon cancer cells by the Wnt/β-catenin signaling pathway [J]. Oncology Letters, 2018, 35(8): 623-630.
|
[10] |
Liu P, Shen JK, Hornicek FJ, et al. Wnt inhibitory factor 1 (WIF1) methylation and its association with clinical prognosis in patients with chondrosarcoma [J]. Sci Rep, 2017, 7(1): 1580-1586.
|
[11] |
Xinmei L, Sujuan Y, Qianqian J, et al. Wnt inhibitory factor-1-mediated autophagy inhibits Wnt/β-catenin signaling by downregulating dishevelled-2 expression in non-small cell lung cancer cells [J]. International Journal of Oncology, 2018, 11(9): 492-498.
|
[12] |
Novellasdemunt L, Foglizzo V, Cuadrado L, et al. USP7 Is a tumor-specific WNT activator for, APC-mutated colorectal cancer by mediating β-catenin deubiquitination [J]. Cell Reports, 2017, 21(3): 612-627.
|
[13] |
Ghasemi A, Ghotaslou A, Mohammadi M, et al. Methylation of the wnt signaling antagonist, wnt inhibitory factor 1 and dickkopf-1 genes in acute myeloid leukemia at the time of diagnosis [J]. Zahedan Journal of Researches in Medical Sciences, 2016, 18(1): 75-82.
|
[14] |
Li S, Han Z, Zhao N, et al. Inhibition of DNMT suppresses the stemness of colorectal cancer cells through down-regulating Wnt signaling pathway [J]. Cellular Signalling, 2018, 42(9): 41-47.
|
[15] |
Cuadrado HJ, Hark PH, Joe JB. Inhibition of Wnt signaling by silymarin in human colorectal cancer cells [J]. Biomolecules & Therapeutics, 2016, 24(4): 380-386.
|
[16] |
Reabroi S, Saeeng R, Boonmuen N, et al. The anti-cancer activity of an andrographolide analogue functions through a GSK-3β-independent Wnt/β-catenin signaling pathway in colorectal cancer cells [J]. Scientific Reports, 2018, 8(6): 653-660.
|
[17] |
Mcmanus S, Chababi W, Arsenault D, et al. Dissecting oncogenic RTK pathways in colorectal cancer initiation and progression [J]. Methods Mol Biol, 2018, 1765(9): 27-42.
|
[18] |
Kerekes K, Bányai L, Patthy L. Wnts grasp the WIF domain of Wnt Inhibitory Factor 1 at two distinct binding sites [J]. Febs Letters, 2016, 589(20): 3044-3051.
|
[19] |
Wang W, Li Q, Yang T, et al. Anti-cancer effect of Aquaporin 5 silencing in colorectal cancer cells in association with inhibition of Wnt/β-catenin pathway [J]. Cytotechnology, 2018, 35(11): 27-33.
|
[20] |
Chang J, Tang N, Fang Q, et al. Inhibition of COX-2 and 5-LOX regulates the progression of colorectal cancer by promoting PTEN and suppressing PI3K/AKT pathway [J]. Biochemical and Biophysical Research Communications, 2018, 5(7): 96-101.
|